Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

ThromboGenics to Present at the J.P. Morgan Annual Healthcare Conference 2015 in San Francisco

22 Dec 2014

Leuven, Belgium – 22 December, 2014 - ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces that its Chief Executive Officer Dr Patrik De Haes will be presenting at the 33rd J.P. Morgan Annual Healthcare Conference (12-15 January, 2015).

Details of the presentation are as follows:

Date: 15 January 2015
Time: 10 am PST
Venue: Westin St. Francis Hotel, San Francisco, CA - Elizabethan C/ Victorian Room

Copies of the presentation will be made available at